Replies to post #120550 on Biotech Values

[biomaven0]

So here's a challenge for you and the Board - come up with a hedged HCV portfolio. Something along the lines of 5 stocks long and 5 stocks short.

(I'd start it off myself except I'm really not qualified to play in this complex space - my only current position is an all-to-modest position in VRUS acquired a few months back).

Peter

[mcbio]

Since ANA773 is not particularly effective against HCV, ANDS figures they might as well test it in cancer

They should just go ahead and merge with PPHM and have numerous disease categories addressed by only two drugs.